CVS Health Insights Report Tackles Complex Issue of Medication Adherence

Published on:

WOONSOCKET, R.I., Oct. 2, 2014- A new Insights Report published today by the CVS Health Research Institute entitled, "Adherence: why it's so hard and what we can do about it," reviews the Company's key research findings on medication adherence and lays out its goal to increase adherence by five to 15 percent through new interventions by 2017. For the past several years, the CVS Health Research Institute has been focused on building the body of scientific knowledge available related to medication adherence and, through various research collaborations, has published or presented more than 50 adherence-focused papers in peer-reviewed journals and at various clinical conferences. The Insights Report describes complex adherence challenges and actions that can make adherence easier while helping to lower overall costs.

"The reasons why people don't take their medications for chronic conditions as prescribed by their health care provider are very personal and complex," said William Shrank, M.D., Chief Scientific Officer of CVS Health. "Over the past several years CVS Health has invested in research to help the industry better understand medication non-adherence. Our goal now is to apply this knowledge and develop new interventions that will enable us to improve adherence for the patients we support."

The new Insights publication focuses on four key areas of CVS Health medication adherence research to date, serving as a useful resource illustrating the impact of the issue of medication adherence on the health care system. In each section, the report summarizes relevant research and highlights programs and initiatives designed to address the identified issues. The four areas include:

  • Adherence starts when the Rx is written – How to reduce primary non-adherence, those instances when the patient does not pick up their first fill for a prescription.
  • Pharmacist counseling and support can make a difference – The report details the innovations implemented by CVS Health to enable effective counseling at its retail pharmacies.
  • The hard work of adherence takes place at home – How best to support patients in their day-to-day medication regimens based on their individual needs and barriers.
  • The role pharmacy benefit plan designs play in supporting adherence – Strategic plan design can help by reducing barriers such as cost, medication complexity and forgetfulness.

"We are actively piloting and testing a number of interventions to help make it easier for our patients to be more adherent," added Dr. Shrank. "For example, we know through our research that it is difficult for patients to be optimally adherent when they have numerous health care providers, take multiple medications with different dosing regimens, and make several trips a month to the pharmacy to pick up prescriptions.  As a result we are actively engaged in a variety of pilots to test prescription synchronization programs and innovative medication labeling and packaging."

The CVS Health Research Institute is focused on contributing to the body of scientific knowledge related to pharmacy and health care through research collaborations with external academic institutions, participation in federally-funded research, analysis and sharing of CVS Health data sources and coordination of pilot programs and initiatives.  CVS Health Research Institute findings support a continuous quality improvement environment, which encourages product innovation and development to benefit CVS Health patients, clients and their members.

To view the Insights report, please visit the following link:  cvshealth.com/insights-adherence2014

About CVS Health

CVS Health (NYSE: CVS) is a pharmacy innovation company helping people on their path to better health.  Through our 7,700 retail pharmacies, 900 walk-in medical clinics, a leading pharmacy benefits manager with nearly 65 million plan members, and expanding specialty pharmacy services, we enable people, businesses and communities to manage health in more affordable, effective ways.  This unique integrated model increases access to quality care, delivers better health outcomes and lowers overall health care costs.  Find more information about how CVS Health is shaping the future of health at www.cvshealth.com.

Media Contact:
Christine Cramer
CVS Health
(401)770 3317
christine.cramer@cvscaremark.com

Logo - http://photos.prnewswire.com/prnh/20140903/142305

SOURCE CVS Health

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.